Hot Paths

Merck’s Bio-Techne buyout put Life Sciences sector in focus: Top quant-rated stocks

Press Room
Jun 25, 2026, 1:28 PM ETState Street Health Care Select Sector SPDR ETF (XLV), VHT, IYH, XHE, IHI, IDNA, PBE, XBIDHR, ILMN, WST, WAT, TECH, PACB, MKGAF, MKKGY, SP500, PSNL, TXG, MRVI, ABCL, FTRE, HOLDBy: Sara Sethiya, SA News Editor
Health insurance and financial assurance concept with hospital investment as future asset advantage for medical security, growth, and strategic decision planning.

Father-Studio/iStock via Getty Images

The life sciences tools and services sector is back in focus after Merck KGaA (MKGAF) agreed to acquire Bio-Techne (TECH) for $73 per share in cash, valuing the deal at an enterprise value of around $11.3B (€9.9B).

The offer is

Exit mobile version